Miguel Botto

Angiotech Pharmaceuticals, Inc. is a global specialty pharmaceutical and medical device company, which engages in developing, manufacturing and marketing medical products and technologies, within the areas of interventional oncology, wound closure and ophthalmology. The company was founded by William L. Hunter and Cruz F. Tony in 1992 and is headquartered in Vancouver, Canada.

NeuroMedix, Inc. develops pharmaceutical products. The company makes therapeutic agents for the treatment of degenerative and inflammatory diseases of the central nervous system, such as Alzheimer's disease and multiple sclerosis. It also develops therapies for the treatment of other degenerative neuroinflammatory diseases, such as Parkinson's. NeuroMedix was founded in 2005 and is headquartered in Toronto, Canada.

Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada.

Biocant Ventures SA (Biocant) is an Independent Venture Capital firm founded in 2006. The firm is headquartered in Cantanhede.

Proterris (Portugal) - Investigação e Desenvolvimento de Produtos Farmacêuticos, Sociedade Unipessoal Lda. develops Carbon Monoxide-Releasing Molecules (CORMs) for therepy. The company was founded by Carlos José Rodrigues Crispim Romão, Werner Ernest Hass, Nuno Manuel de Castro Santos Arante e Oliveira and Stan Kugell on January 4, 2002 and is headquartered in Oeiras, Portugal.

Founded in 1923, Mount Sinai Hospital (Canada) operates a hospital. The company is based in Toronto, Canada.

BIOTECanada serves as a national association for Canada's health, industrial and agricultural biotechnology sectors. The company was founded in 1986 and is headquartered in Ottawa, Canada.

Critical Links SA provides information technology services. It offers solutions to aerospace, energy, health-care, and telecom sectors. The company was founded by João Fernando Viegas Carreira in 2006 and is headquartered in Coimbra, Portugal.

Critical Software SA develops and provides operations support software solutions. It serves clients from the aerospace, defense, transportation, telecommunications, energy, healthcare, and finance industries. The firm offers solutions for business intelligence, data security, energy management, network administration, application development, infrastructure auditing, and systems migration. The company was founded by Gonçalo Quadros and Diamantino Costa in 1998 and is headquartered in Coimbra, Portugal.

Bluepharma Indústria Farmacêutica SA develops, manufactures, and markets pharmaceutical drugs The firm operates through the following business areas: Production of Pharmaceutical Drugs for Bluepharma and Other Companies; Research, Development, and Registration of Pharmaceutical Drugs; and Marketing of Generic Pharmaceutical Drugs. Its services include licensing, contract manufacturing, product development, and research and development. The company was founded in February 2001 and is headquartered in Coimbra, Portugal.

Critical Ventures - Sociedade de Capital de Risco SA (Critical Ventures) is the venture capital subsidiary of Critical SGPS Lda. It was founded in 2009 and is headquartered in Coimbra, Portugal.

Pathena SA (Pathena) is an independent venture capital firm founded in 2002 by Antonio Murta, Jorge Manuel de Sousa Brás and Vitor Dinis. Pathena SA is headquartered in Porto, Portugal.

Retmarker SA provides ophthalmology-specific software solutions for clinical decision support and electronic medical record. Its products include RetmarkerC, deals with the process of automatically co-registering (overlapping) different images and RetmarkerAMD Research automatically counts lesions (in number and area) by lesion type and location (sub-field). The company was founded by Diamantino Costa, Manuel Goncalo Lopes de Almeida Quadros and Ricardo Cunha-Vaz in 2008 and is headquartered in Coimbra, Portugal.

Critical Manufacturing SA develops software of manufacturing execution systems. It offers integration and networking of machines and systems, IT systems, and cloud solutions. The company was founded by Adélio Marco da Costa Fernandes, Lau Yong Wun, João Rafael Ribeiro Cortez, Teresa Isabel de Jesus Carreiro, Francisco Sobrinho Simões de Almada Lobo and Reiner Joachim Missale on March 11, 2009 and is headquartered in Maia, Portugal.

LaserLeap Technologies SA provides biomedical science and research services. Its technology is applied in cosmetics, anaesthetics and analgesics, therapeutics and vaccines. The company was founded in 2011 by Luis Guilherme da Silva Arnaut Moreira, Carlos Alberto Lourenço de Serpa Soares and Gonçalo de F.F. Sa and is headquartered in Coimbra, Portugal.

Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada.

Ebankit Omnichannel Innovation SA develops digital platforms for the financial sector. It offers banking solutions. The company was founded by Alexandre Azevedo Viana, Joao Miguel Pereira Lima Pinto, Jose Jorge Monteiro Ferreira and Manuel Renato Cruz Antunes De Oliveira in January 2014 and is headquartered in Porto, Portugal.

Mercal Capital Corp. is a capital pool company, which engages in the identification and evaluation of potential acquisitions or businesses. The company was founded on August 31, 2015 and is headquartered in Ottawa, Canada.

Blueclinical, Ltd. operates as a translational medicine company. It develops medicines and medical devices. It offers innovative services to institutions, startups and established companies. The company was founded by José Luís Almeida in 2012 and is headquartered in Matosinhos, Portugal.

Oceano Fresco SA develops and produces bivalves varieties for shellfish farmers. The company was founded by De Carvalho Bernardo Ferreira in 2015 and is headquartered in Mira, Portugal.